Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis.
<h4>Background and aim</h4>A large number of studies have tried to combine sorafenib with TACE for patients with unresectable hepatocellular carcinoma (HCC) and the results were controversial. We conducted this systematic review and meta-analysis to evaluate the safety and efficacy of co...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0091124 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|